Literature DB >> 6326748

Isolation of the native form of chicken gizzard myosin light-chain kinase.

P K Ngai, C A Carruthers, M P Walsh.   

Abstract

A simple and rapid procedure for the purification of the native form of chicken gizzard myosin light-chain kinase (Mr 136000) is described which eliminates problems of proteolysis previously encountered. During this procedure, a calmodulin-binding protein of Mr 141000, which previously co-purified with the myosin light-chain kinase, is removed and shown to be a distinct protein on the basis of lack of kinase activity, different chymotryptic peptide maps, lack of cross-reactivity with a monoclonal antibody to turkey gizzard myosin light-chain kinase, and lack of phosphorylation by the purified catalytic subunit of cyclic AMP-dependent protein kinase. This Mr-141000 calmodulin-binding protein is identified as caldesmon on the basis of Ca2+-dependent interaction with calmodulin, subunit Mr, Ca2+-independent interaction with skeletal-muscle F-actin, Ca2+-dependent competition between calmodulin and F-actin for caldesmon, and tissue content.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326748      PMCID: PMC1153416          DOI: 10.1042/bj2180863

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Phosphorylation of smooth muscle myosin light chain kinase by the catalytic subunit of adenosine 3': 5'-monophosphate-dependent protein kinase.

Authors:  R S Adelstein; M A Conti; D R Hathaway; C B Klee
Journal:  J Biol Chem       Date:  1978-12-10       Impact factor: 5.157

2.  Modulator protein as a component of the myosin light chain kinase from chicken gizzard.

Authors:  R Dabrowska; J M Sherry; D K Aromatorio; D J Hartshorne
Journal:  Biochemistry       Date:  1978-01-24       Impact factor: 3.162

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Smooth muscle myosin light chain kinase.

Authors:  M P Walsh; S Hinkins; R Dabrowska; D J Hartshorne
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Purification and characterization of smooth muscle myosin light chain kinase.

Authors:  R S Adelstein; C B Klee
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

Review 6.  Calmodulin-dependent myosin light chain kinases.

Authors:  M P Walsh
Journal:  Cell Calcium       Date:  1981-08       Impact factor: 6.817

Review 7.  Regulation and kinetics of the actin-myosin-ATP interaction.

Authors:  R S Adelstein; E Eisenberg
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

8.  The binding of smooth muscle myosin light chain kinase to actin.

Authors:  R Dabrowska; S Hinkins; M P Walsh; D J Hartshorne
Journal:  Biochem Biophys Res Commun       Date:  1982-08-31       Impact factor: 3.575

9.  Purification of muscle actin.

Authors:  J D Pardee; J A Spudich
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

10.  Purification of a calmodulin-binding protein from chicken gizzard that interacts with F-actin.

Authors:  K Sobue; Y Muramoto; M Fujita; S Kakiuchi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

View more
  45 in total

1.  Inhibition of Rho-associated kinase blocks agonist-induced Ca2+ sensitization of myosin phosphorylation and force in guinea-pig ileum.

Authors:  K Swärd; K Dreja; M Susnjar; P Hellstrand; D J Hartshorne; M P Walsh
Journal:  J Physiol       Date:  2000-01-01       Impact factor: 5.182

2.  Myosin regulatory light chain diphosphorylation slows relaxation of arterial smooth muscle.

Authors:  Cindy Sutherland; Michael P Walsh
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

3.  The effects of phosphorylation of smooth-muscle caldesmon.

Authors:  P K Ngai; M P Walsh
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

4.  The effects of caldesmon extraction on mechanical properties of skinned smooth muscle fibre preparations.

Authors:  U Malmqvist; A Arner; R Makuch; R Dabrowska
Journal:  Pflugers Arch       Date:  1996-06       Impact factor: 3.657

5.  Targeting Pim Kinases and DAPK3 to Control Hypertension.

Authors:  David A Carlson; Miriam R Singer; Cindy Sutherland; Clara Redondo; Leila T Alexander; Philip F Hughes; Stefan Knapp; Susan B Gurley; Matthew A Sparks; Justin A MacDonald; Timothy A J Haystead
Journal:  Cell Chem Biol       Date:  2018-07-19       Impact factor: 8.116

6.  Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro.

Authors:  K A Qatsha; C Rudolph; D Marmé; C Schächtele; W S May
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

7.  Myosin light chain kinase steady-state kinetics: comparison of smooth muscle myosin II and nonmuscle myosin IIB as substrates.

Authors:  Diego B Alcala; Brian D Haldeman; Richard K Brizendine; Agata K Krenc; Josh E Baker; Ronald S Rock; Christine R Cremo
Journal:  Cell Biochem Funct       Date:  2016-08-16       Impact factor: 3.685

8.  Phosphorylation of caldesmon by smooth-muscle casein kinase II.

Authors:  C Sutherland; B S Renaux; D J McKay; M P Walsh
Journal:  J Muscle Res Cell Motil       Date:  1994-08       Impact factor: 2.698

9.  Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin: method of analysis of interactions of tight-binding ligands with target protein.

Authors:  A Takai; K Sasaki; H Nagai; G Mieskes; M Isobe; K Isono; T Yasumoto
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

10.  Caldesmon and a 20-kDa actin-binding fragment of caldesmon inhibit tension development in skinned gizzard muscle fiber bundles.

Authors:  G Pfitzer; C Zeugner; M Troschka; J M Chalovich
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.